Navigation Links
RAD001 Shows Potential to Reverse Resistance to Herceptin(R)* in Metastatic Breast Cancer Patients, Leading to Phase III Trial
Date:12/12/2008

ents had stable disease and two patients had progressive disease. The critical dose-limiting toxicities (i.e., dose-limiting toxicities in cycle 1) occurring in the 5 mg daily treatment group included grade 3/4 neutropenia, grade 3 stomatitis, grade 3 fatigue and grade 3 anorexia. In the 30 mg weekly treatment group, grade 3/4 neutropenia was the only critical dose-limiting toxicity. There were no critical dose-limiting toxicities in the 20 mg weekly RAD001 treatment arm. The most commonly reported grade 3/4 adverse events (greater than or equal to 10%) suspected of being related to study treatment were neutropenia, stomatitis and leukopenia.

About breast cancer

In the US, invasive breast cancer affects one in eight women. It is the second most common cancer among women in the US and the second leading cause of cancer-related death in women. Breast cancer is expected to claim the lives of approximately 40,500 women in 2008.

Inside a breast there are many lobes, ducts and vessels that support several important functions in the body, including reproductive needs and fighting infection. In breast cancer, some of the cells in the breast begin growing abnormally and divide more rapidly than healthy cells. The quick division of cells may cause spreading through the breast, to the lymph nodes or to other parts of the body.

About RAD001

RAD001, an oral once-daily inhibitor of mTOR, is an investigational drug being studied in multiple tumor types. In cancer cells, RAD001 provides continuous inhibition of mTOR, a protein that acts as a central regulator of tumor cell division, cell metabolism and blood vessel growth.

The safety and efficacy profile of RAD001 has not yet been established in oncology and there is no guarantee that RAD001 will become commercially available for oncology indications. The active ingredient in RAD001 is everolimus. The active ingredient everol
'/>"/>

SOURCE Novartis Pharmaceuticals Corporation
Copyright©2008 PR Newswire.
All rights reserved

2

GOOD

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Latest RAD001 Study Results Show Further Increase in Time Without Tumor Growth in Patients With Advanced Kidney Cancer
2. RAD001 Combined with Sandostatin LAR(R) Depot and as Monotherapy Controls Growth of Rare Pancreatic Neuroendocrine Tumors
3. RAD001 Granted Priority Review in the US Based on Potential to Fill Unmet Medical Need in Patients With Advanced Kidney Cancer
4. Early Data Presented at ASCO Show Potential of RAD001 to Enhance Efficacy of, and Overcome Resistance to, Breast Cancer Treatments
5. RAD001 More Than Doubles Time Without Tumor Growth After Failure of Standard Treatment in Patients With Advanced Kidney Cancer
6. Everolimus (RAD001) Significantly Extends Progression-Free Survival in Advanced Kidney Cancer Patients After Failure of Other Targeted Therapy
7. New Study Shows PCR and FCR Have Significant Activity in B-cell Chronic Lymphocytic Leukemia
8. Study Shows ACCU-CHEK(R) Blood Glucose Monitoring Systems and Lancing Devices Are Least Painful
9. Dramatic JUPITER Findings Fail to Sway Prescribing Behavior, Poll Shows
10. Third Pivotal Phase 3 Study for NicOx Naproxcinod Shows Positive Efficacy, Safety and Blood Pressure Results
11. Soft Contact Lenses Do Not Lead to Myopic Creep in Children, Study Shows
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... May 21, 2013 On its tenth ... product developments at the Special Libraries Association PHTD meeting in ... focus on product literature databases and workflow solutions for the ... said founding director Nigel Johnson . "At ... to our clients and what better forum to announce them ...
(Date:5/21/2013)... May 21, 2013  Zacks.com announces the list of ... Zacks Equity Research analysts discuss the latest news and ... featured in the blog include Actavis, Inc.,s (NYSE: ... SA (NYSE: TOT ), Petrobras (NYSE: PBR ... (Logo: http://photos.prnewswire.com/prnh/20101027/ZIRLOGO ) ...
(Date:5/21/2013)... RICHLAND, Wash. , May 21, 2013  IsoRay, ... announced today that it has entered into an exclusive ... of IsoRay,s complete product line in Greece ... innovator in seed brachytherapy and medical radioisotope applications for ... cancer and gynecologic ("gyn") cancer. IASIS ...
Breaking Medicine Technology:Pi2 Solutions' 10th Anniversary Heralds New Corporate Image as Platinum Sponsor of SLA PHT Meeting in Philadelphia 2Pi2 Solutions' 10th Anniversary Heralds New Corporate Image as Platinum Sponsor of SLA PHT Meeting in Philadelphia 3The Zacks Analyst Blog Highlights: Actavis, BP, Total, Petrobras and Devon Energy 2The Zacks Analyst Blog Highlights: Actavis, BP, Total, Petrobras and Devon Energy 3The Zacks Analyst Blog Highlights: Actavis, BP, Total, Petrobras and Devon Energy 4The Zacks Analyst Blog Highlights: Actavis, BP, Total, Petrobras and Devon Energy 5IsoRay Announces A New International Distributor For Greece 2IsoRay Announces A New International Distributor For Greece 3
(Date:5/21/2013)... Boca Raton, Fla. (PRWEB) May 21, 2013 ... TV program distributed on cable networks and cable channels ... of new episodes on its YouTube channel. The producers ... profiles of companies in the shipping industry, the manufacturing ... program highlights pioneering medical facilities and medical practitioners in ...
(Date:5/21/2013)... May 21, 2013 Global Proving Ground ... Bodybuilding.com, the largest online retailer of health and fitness ... reality-based sports show, Warrior Island. “We cast the ... Facebook & Twitter, with our unique social networking platform,” ... these elite fighters on an island in the Pacific ...
(Date:5/21/2013)... AURORA, Colo. (May 21, 2013) A paper recently ... and co-written by physicians and scientists at the ... important genetic risk factor for pulmonary fibrosis can be ... lung disease. , Researchers looked at a fairly common ... is a component of the mucous produced by the ...
(Date:5/21/2013)... CINCINNATIUsing the Department of Defense Serum Repository (DoDSR), University ... biomarkers for inflammatory bowel disease (IBD), which could help ... not yet shown symptoms. , This finding, the first ... MD, is being presented via podium presentation by staff ... Disease Week 2013, being held May 18-21 in Orlando, ...
(Date:5/21/2013)... The nation’s first trial involving a ... its conclusion in Washington state court, Bernstein Liebhard LLP ... an attorney for the Plaintiffs compared Intuitive Surgical to ... sales and services for its customers. Intuitive ... of surgeons, to keep control of hospitals and keep ...
Breaking Medicine News(10 mins):Health News:In View hosted by Larry King Announces New Videos on its YouTube Channel 2Health News:Bodybuilding.com Partners with Global Proving Ground’s New Reality Show Warrior Island 2Health News:Bodybuilding.com Partners with Global Proving Ground’s New Reality Show Warrior Island 3Health News:Researchers find genetic risk factor for pulmonary fibrosis 2Health News:Biomarkers discovered for inflammatory bowel disease 2Health News:Da Vinci Surgery Robot Lawsuit News: Bernstein Liebhard LLP Comments on Closing Arguments in Nation’s First Da Vinci Lawsuit Trial 2Health News:Da Vinci Surgery Robot Lawsuit News: Bernstein Liebhard LLP Comments on Closing Arguments in Nation’s First Da Vinci Lawsuit Trial 3Health News:Da Vinci Surgery Robot Lawsuit News: Bernstein Liebhard LLP Comments on Closing Arguments in Nation’s First Da Vinci Lawsuit Trial 4
... use of combined treatments for severe acute pancreatitis ... resulting in shorter hospitalizations and fewer radiological procedures ... Clinical Gastroenterology and Hepatology , the official ... In a related study, doctors found that patients ...
... parents wanting to reduce the negative influence of TV on their ... set. But a new study suggests that might not be ... watch a lot of TV, might be even more damaging to ... Department of Global Health and Social Medicine examined the link ...
... shows that loss of a gene called NFKBIA promotes the ... of brain cancer, and suggests that therapies that stabilize this ... study was published recently in the New England Journal ... be an independent predictor of survival in certain patients with ...
... the most widely produced fruit in the world and ... a nutrient which could tackle the onset of vascular ... Nutrition & Food Research , reveals that an extracted ... team led by Dr Teruo Kawada, from Kyoto University ...
... 2011Wiley-Blackwell, the scientific, technical, medical, and scholarly publishing ... and JWb), announced today that an additional 88 ... through the three United Nations sponsored Research4Life programs ... cost access to and training for academic and ...
... , THURSDAY, Jan. 6 (HealthDay News) -- The organs ... in newborn intensive care units (NICUs) would be eligible for ... and young children, according to a new study. Children ... the more than 200,000 people in the United States on ...
Cached Medicine News:Health News:Less invasive techniques help manage complications of severe pancreatic disease 2Health News:Less invasive techniques help manage complications of severe pancreatic disease 3Health News:Secondhand television exposure linked to eating disorders 2Health News:Secondhand television exposure linked to eating disorders 3Health News:Loss of gene promotes brain-tumor development, reduces survival, study finds 2Health News:Wiley-Blackwell announces 102 additional products available through Research4Life 2Health News:Infant Organ Donors Could Help Meet Transplant Needs: Study 2
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: